Dr. Escipion Pedroza
NPI #1306807771

Endocrinology, Diabetes & Metabolism Doctor located in Metairie, LA

4213 Saxon St
Suite 200
Metairie, LA 70006-4187
(504) 454-2816


Dr. Escipion Pedroza is a male Endocrinology, Diabetes & Metabolism Doctor (taxonomy code 207RE0101X) located in Metairie, Louisiana. Dr. Escipion Pedroza's NPI Number is #1306807771 and has been listed in the NPI registry for 12 years. Dr. Escipion Pedroza's practice location is listed as: 4213 Saxon St Suite 200 Metairie, LA 70006-4187 and can be reached via phone at (504) 454-2816.

Contact Information

NPI Number
Not provided

4213 Saxon St
Suite 200
Metairie, LA 70006-4187


Business Information

Is Sub-Organization?
Not Available
Parent Organization Name
Not Applicable

About This listing

Last Updated
12/3/2013 4 years ago
Date Added
3/28/2006 12 years ago
Viewed On
6/24/2018 just now

Endocrinology, Diabetes & Metabolism Taxonomy Info

The taxonomy code for Dr. Escipion Pedroza's main specialty, Endocrinology, Diabetes & Metabolism, is 207RE0101X. An internist who concentrates on disorders of the internal (endocrine) glands such as the thyroid and adrenal glands. This specialist also deals with disorders such as diabetes, metabolic and nutritional disorders, obesity, pituitary diseases and menstrual and sexual problems.

Click here to see more information about this taxonomy and find other providers that specialize in Endocrinology, Diabetes & Metabolism


Be the first to rate Dr. Pedroza

Thanks for sharing your opinion!

‡ Descriptions, provider messages, and reviews are user submitted. While we make our best effort to verify the accuracy of information submissions, DocBios cannot guarantee that the information is accurate and/or up to date. Please verify any and/or all information with the provider. DocBios is not an advice or referral service and does not guarantee, approve, or endorse any particular healthcare provider.

Health Care Providers Nearby


Thanks! Your edit was sucessfully submitted. Changes will be displayed after DocBios.com editors have reviewed your submission.